Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Mar 26;56(4):e01907-17.
doi: 10.1128/JCM.01907-17. Print 2018 Apr.

Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations

Mariana Castanheira  1
Affiliations
Comment

Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations

Mariana Castanheira. J Clin Microbiol. .

Abstract

Recent changes in the occurrence of fungal species and the difficulties in performing reference antifungal susceptibility testing highlight the importance of surveillance of fungal organisms and antifungal resistance rates. K. M. T. Astvad et al. report results from recent (2012 to 2015) fungemia surveillance in Denmark and compare the results to previous data (2004 to 2011), showing a decrease in Candida albicans infections accompanied by an increase in C. glabrata and C. dubliniensis infections (J Clin Microbiol 56:e01564-17, 2018, https://doi.org/10.1128/JCM.01564-17). Azole resistance among C. tropicalis and C. parapsilosis isolates and echinocandin resistance in C. krusei isolates were higher in Denmark than in other regions. Interestingly, the usage of antifungals is higher in Denmark than in other Nordic countries.

PubMed Disclaimer

Comment on

References

    1. Ostrosky-Zeichner L, Pappas PG. 2006. Invasive candidiasis in the intensive care unit. Crit Care Med 34:857–863. doi:10.1097/01.CCM.0000201897.78123.44. - DOI - PubMed
    1. Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3–S13. doi:10.1016/j.amjmed.2011.11.001. - DOI - PubMed
    1. Bassetti M, Peghin M, Timsit JF. 2016. The current treatment landscape: candidiasis. J Antimicrob Chemother 71:ii13-ii22. doi:10.1093/jac/dkw392. - DOI - PubMed
    1. Lamoth F, Calandra T. 2017. Early diagnosis of invasive mould infections and disease. J Antimicrob Chemother 72:i19–i28. doi:10.1093/jac/dkx030. - DOI - PubMed
    1. Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA, Weissfeld AS, Weinstein MP, Liebow EB, Wolk DM. 2016. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29:59–103. doi:10.1128/CMR.00053-14. - DOI - PMC - PubMed

Substances

LinkOut - more resources